Cargando…

OUTCOME MEASURES: EP.324 TREAT-NMD remote outcome measures group - consensus guidelines and recommendations

Detalles Bibliográficos
Autores principales:	Lowes, L., Alfano, L., Bendixen, R., Hardy-Bosson, E., James, M., Laubscher, K., Leffler, M., Lilien, C., Mayhew, A., Simon, S. Segovia, Wallace, J., Jain, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487896/ http://dx.doi.org/10.1016/j.nmd.2021.07.349

Ejemplares similares

OUTCOME MEASURES: EP.325 Remote testing: is it worth the effort? Feasibility in the clinical and research setting
por: Powers, B., et al.
Publicado: (2021)

COVID-19 AND NEUROMUSCULAR DISEASES: EP.24 COVID-19 mitigation strategies for outcome measure assessments, training, and endpoint collection in clinic, clinical trials and natural history studies
por: James, M., et al.
Publicado: (2021)

A regulated NMD mouse model supports NMD inhibition as a viable therapeutic option to treat genetic diseases
por: Echols, Josh, et al.
Publicado: (2020)

Elucidation of the Mechanism of Host NMD Suppression by HTLV-1 Rex: Dissection of Rex to Identify the NMD Inhibitory Domain
por: Nakano, Kazumi, et al.
Publicado: (2022)

NMD monitors translational fidelity 24/7
por: Celik, Alper, et al.
Publicado: (2017)

Environmental stresses suppress nonsense-mediated mRNA decay (NMD) and affect cells by stabilizing NMD-targeted gene expression
por: Usuki, Fusako, et al.
Publicado: (2019)

Large-Scale Evidence for Conservation of NMD Candidature Across Mammals
por: de Lima Morais, David A., et al.
Publicado: (2010)

Reviewers BJCVS 32.4
Publicado: (2017)

Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases
por: Duong, Tina, et al.
Publicado: (2021)

Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies
por: Durand, Sébastien, et al.
Publicado: (2007)

The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument
por: Mokkink, Lidwine B., et al.
Publicado: (2016)

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
por: Maahs, David M., et al.
Publicado: (2016)

The salicylic acid dependent and independent effects of NMD in plants
por: Rayson, Samantha, et al.
Publicado: (2012)

Human NMD ensues independently of stable ribosome stalling
por: Karousis, Evangelos D., et al.
Publicado: (2020)

Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM)
por: McNamara, Robert L, et al.
Publicado: (2015)

Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
por: Koeks, Zaïda, et al.
Publicado: (2017)

Health Tract No. 324: Stomach Couch
Publicado: (1868)

A Consensus Set of Outcomes for Parkinson’s Disease from the International Consortium for Health Outcomes Measurement
por: de Roos, Paul, et al.
Publicado: (2017)

Splicing-dependent NMD does not require the EJC in Schizosaccharomyces pombe
por: Wen, Jikai, et al.
Publicado: (2010)

Longevity regulation by NMD-mediated mRNA quality control
por: Son, Heehwa G., et al.
Publicado: (2017)

Selective destabilization of polypeptides synthesized from NMD-targeted transcripts
por: Chu, Vincent, et al.
Publicado: (2021)

A regional consensus recommendation on brain atrophy as an outcome measure in multiple sclerosis
por: Alroughani, Raed, et al.
Publicado: (2016)

324 MHz RF deflector design and test
por: Fu, S, et al.
Publicado: (1998)

P324 Phylogenetic and ecological overview of Onygenales
por: Kandemir, Hazal, et al.
Publicado: (2022)

The role of the NMD factor UPF3B in olfactory sensory neurons
por: Tan, Kun, et al.
Publicado: (2020)

Association between NMD3 and symptoms of Parkinson’s disease in Chinese patients
por: Wu, Hui, et al.
Publicado: (2020)

Recurrent SRSF2 mutations in MDS affect both splicing and NMD
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2020)

Nanopore sequencing reveals endogenous NMD-targeted isoforms in human cells
por: Karousis, Evangelos D., et al.
Publicado: (2021)

The NMD Pathway Regulates GABARAPL1 mRNA during the EMT
por: Baudu, Timothée, et al.
Publicado: (2021)

Progression of the pluripotent epiblast depends upon the NMD factor UPF2
por: Chousal, Jennifer N., et al.
Publicado: (2022)

324. Outcomes of Immunomodulatory and Biologic Therapy in People Living with HIV: A Report from Two Academic Hospitals
por: Peluso, Michael J, et al.
Publicado: (2019)

Cystic Fibrosis in Europe - remote measurement of outcome
por: Mehta, Anil, et al.
Publicado: (2010)

In Silico Analysis of the Structural and Biochemical Features of the NMD Factor UPF1 in Ustilago maydis
por: Martínez-Montiel, Nancy, et al.
Publicado: (2016)

Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a ‘core outcome set’
por: Prinsen, Cecilia A C, et al.
Publicado: (2014)

Increased hippocampal excitability in miR-324-null mice
por: Hayman, Dan J., et al.
Publicado: (2021)

Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway
por: Belew, Ashton Trey, et al.
Publicado: (2014)

The Cellular NMD Pathway Restricts Zika Virus Infection and Is Targeted by the Viral Capsid Protein
por: Fontaine, Krystal A., et al.
Publicado: (2018)

EPS4.3 Differential sensitivity of outcome measures that assess progression of mild CF lung disease in school age children
por: Robinson, T.E., et al.
Publicado: (2017)

324 Evaluation of Chest Computed Tomography in Patients with Asthma
por: Montenegro, Fernanda Guerra, et al.
Publicado: (2012)

324 Improved intra-operative Hand Hygiene Compliance
por: Loftus, Randy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7fa5n70m4t6mcv4b2uf38nconh